期刊
GASTROENTEROLOGY
卷 132, 期 4, 页码 1410-1419出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2007.02.054
关键词
-
Background & Aims: ELF3, a member of the ETS transcription factor family, has been shown to transactivate the transforming growth factor beta type 11 receptor (TGF-beta RII) promoter. Previously we showed that Elf3-null mice have a defect in the small intestine caused by a failure of small intestinal epithelial cells to differentiate and that these cells produced significantly lower levels of Tgf-beta RII. To prove that the defect observed in Elf3-null mice resulted from the lack of Elf3-dependent activation of Tgf-beta RII expression, we performed a genetic rescue. Methods: We generated transgenic mice that express human TGF-beta RII specifically in the intestinal epithelium under the control of the mouse A33 antigen promoter. Mice expressing the A33-TGF-beta RII transgene were mated with Elf3(+/-) mice, and double heterozygous offspring harboring both the transgene and one mutant Elf3 allele were intercrossed. Results: The resultant A33-TGF-beta RII transgenic Elf3(-/-) pups displayed normal small intestinal morphology, while the characteristic abnormality was retained in all Elf3(-/-) mice that did not express the transgene. This phenotypic rescue shows for the first time in vivo that a single gene, Elf3, is the critical upstream regulator of Tgf-beta RII in mouse small intestinal epithelium. Conclusions: This has important implications for our understanding of tissue-specific gene regulation and further strengthens the potential clinical connection between ELF3 and colorectal cancer involving transforming growth factor beta insensitivity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据